AXISCADES Technologies Limited (AXISCADES)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 consolidated revenue 359.1 Cr (+20% y-y), retained business grew 30% y-y
- Retained business EBITDA margin 23% in Q2; ESOP charge reduced from Q3 onwards
- Q3 revenue growth target 30-50% y-y; EBITDA margin post-ESOP ~15-16%
- Q4 revenue growth target ~30% over Q3; EBITDA margin post-ESOP ~20%+
- Divestment Phase 2 closure expected by Feb 2027; one-time gain ~1,100 Cr in Q4
- Defence assured forecast visibility ~5,000 Cr; order book execution 600-720 Cr in H2
- XiDA business expected to double FY26 revenue with triple-digit growth in Q3
- Capex and manufacturing pivot ongoing; MAC facility expected operational in ~1 year
- Management confident on revenue and EBITDA targets; supply chain is main risk
- CFO to retire in Dec 2026; successor Uttam Bhageria appointed
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AXISCADES — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AXISCADES to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on AXISCADES Technologies Limited
Important.
The summary above is generated automatically from AXISCADES Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.